GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Revvity Inc (STU:PKN) » Definitions » Cyclically Adjusted PS Ratio

Revvity (STU:PKN) Cyclically Adjusted PS Ratio : 3.94 (As of May. 26, 2024)


View and export this data going back to 1983. Start your Free Trial

What is Revvity Cyclically Adjusted PS Ratio?

As of today (2024-05-26), Revvity's current share price is €103.40. Revvity's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €26.27. Revvity's Cyclically Adjusted PS Ratio for today is 3.94.

The historical rank and industry rank for Revvity's Cyclically Adjusted PS Ratio or its related term are showing as below:

STU:PKN' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.97   Med: 3.9   Max: 7.91
Current: 3.99

During the past years, Revvity's highest Cyclically Adjusted PS Ratio was 7.91. The lowest was 1.97. And the median was 3.90.

STU:PKN's Cyclically Adjusted PS Ratio is ranked worse than
67.16% of 134 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.38 vs STU:PKN: 3.99

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Revvity's adjusted revenue per share data for the three months ended in Mar. 2024 was €4.840. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €26.27 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Revvity Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Revvity's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revvity Cyclically Adjusted PS Ratio Chart

Revvity Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.61 6.52 7.91 5.13 3.91

Revvity Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.80 4.24 3.93 3.91 3.70

Competitive Comparison of Revvity's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Revvity's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revvity's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Revvity's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Revvity's Cyclically Adjusted PS Ratio falls into.



Revvity Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Revvity's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=103.40/26.27
=3.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revvity's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Revvity's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.84/131.7762*131.7762
=4.840

Current CPI (Mar. 2024) = 131.7762.

Revvity Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 3.592 100.560 4.707
201409 3.698 100.428 4.852
201412 3.153 99.070 4.194
201503 4.292 99.621 5.677
201506 4.414 100.684 5.777
201509 4.426 100.392 5.810
201512 3.675 99.792 4.853
201603 4.022 100.470 5.275
201606 4.345 101.688 5.631
201609 4.164 101.861 5.387
201612 4.878 101.863 6.310
201703 4.362 102.862 5.588
201706 4.395 103.349 5.604
201709 4.190 104.136 5.302
201712 4.864 104.011 6.162
201803 4.691 105.290 5.871
201806 5.402 106.317 6.696
201809 5.171 106.507 6.398
201812 5.957 105.998 7.406
201903 5.159 107.251 6.339
201906 5.733 108.070 6.991
201909 5.754 108.329 6.999
201912 6.495 108.420 7.894
202003 5.288 108.902 6.399
202006 6.443 108.767 7.806
202009 7.289 109.815 8.747
202012 1.717 109.897 2.059
202103 9.765 111.754 11.514
202106 9.070 114.631 10.427
202109 6.365 115.734 7.247
202112 7.176 117.630 8.039
202203 6.906 121.301 7.502
202206 6.697 125.017 7.059
202209 5.681 125.227 5.978
202212 5.544 125.222 5.834
202303 4.984 127.348 5.157
202306 5.219 128.729 5.343
202309 5.060 129.860 5.135
202312 5.174 129.419 5.268
202403 4.840 131.776 4.840

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Revvity  (STU:PKN) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Revvity Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Revvity's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Revvity (STU:PKN) Business Description

Traded in Other Exchanges
Address
940 Winter Street, Waltham, MA, USA, 02451
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.

Revvity (STU:PKN) Headlines